Aegis Sciences Announces Additional Longer Term CDC Contract to Provide Genomic Sequencing of SARS-CoV-2 to Aid Public Health Response to COVID-19

Nashville, Tennessee (April 26, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication…

Nashville, Tennessee (April 26, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative COVID-19 and medication compliance testing services, is pleased to announce that it has entered into a long term agreement with the Centers for Disease Control and Prevention (CDC) to deliver 10,000 SARS-CoV-2 genomic sequences per week to enable strain identification…

Aegis Sciences Corporation announces participation in National Testing Action Plan for K-12 Schools to Safely Reopen

Nashville, Tennessee (April 7, 2021) - The Rockefeller Foundation announced an initiative on March 26, to provide guidance on testing for K-12 public schools…

Nashville, Tennessee (April 7, 2021) - The Rockefeller Foundation announced an initiative on March 26, to provide guidance on testing for K-12 public schools to enable safe in-person learning. The K-12 National Testing Action Program: Connecting Schools with the Nation’s Leading Testing Companies to Safely Reopen (NTAP) connects schools with laboratories and testing partners, including Aegis Sciences…

Aegis Sciences Corporation Expands Novel Psychoactive Substance Testing

Nashville, Tennessee (April 5, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (April 5, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, is pleased to announce the expansion of novel psychoactive substance (NPS) testing to Aegis clients. Testing includes expanded offerings for designer opioids, designer benzodiazepines, synthetic cannabinoids,…

Aegis Sciences Announces Latest Innovation to Detect Patient Urine Substitution

Nashville, Tennessee (March 1, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (March 1, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, is pleased to announce the rollout of BioDetect™ to Aegis clients on March 1, 2021.  Aegis’ dedication to the development of clinically innovative testing solutions led to the creation of BioDetect™, a method designed…

Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing

The expanded relationship covering more than 3,000 locations will allow Walgreens to significantly increase its COVID-19 testing capacity Nashville,…

The expanded relationship covering more than 3,000 locations will allow Walgreens to significantly increase its COVID-19 testing capacity Nashville, Tenn. and Deerfield, Ill., (February 11, 2021) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, and Walgreens today announced an expansion…

Aegis Sciences Corporation Expands Urine Drug Testing for Behavioral Health

Nashville, Tennessee (February 1, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (February 1, 2021) –  Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, is pleased to announce the expansion of behavioral health testing (AcuRiseID™) to Aegis clients on February 1, 2021. Testing is now offered for over 100 medications and illicit drugs. The enhancement includes additional…

Aegis Sciences Corporation launches saliva testing for COVID-19

Aegis now offering a less invasive way of testing some patients for COVID-19

Aegis now offering a less invasive way of testing some patients for COVID-19

Not all labs experiencing testing lag

November 23, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip NASHVILLE, TN (WSMV) - There is a nationwide shortage of the reagents…

November 23, 2020 - Aegis Sciences was featured on WSMV News4 Nashville - view clip NASHVILLE, TN (WSMV) - There is a nationwide shortage of the reagents that labs need for COVID tests, but not all labs are having problems. “Right now, our average turnaround time is 14.2 hours,” Dr. Matthew Hardison, Aegis Labs, said. That’s for the most reliable kind of test, the PCR test. Hardison said the turnaround…

Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus

Nashville, Tennessee (November 16, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (November 16, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services to providers, has launched a combined test for SARS-CoV-2 and influenza A/B virus for individuals suspected of respiratory viral infection consistent with COVID-19. Reducing the spread of respiratory illnesses,…

Oral Fluid Testing Capabilities Expanded to Identify Pertinent Drug Interactions

Nashville, Tennessee (November 9, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance…

Nashville, Tennessee (November 9, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, has launched new oral fluid testing enhancements. To better support healthcare customers during the pandemic, Aegis now offers InterACT Rx™ testing for oral fluid specimens. InterACT Rx is a definitive, mass spectrometry…